Medtronic and Tidepool, a nonprofit organization, have agreed to work together to create an interoperable automated insulin pump system.
Medtronic will develop a future Bluetooth-enabled MiniMed(TM) pump that would be compatible with Tidepool Loop, a future FDA-regulated, open source automated insulin delivery app for iPhone® and Apple Watch® currently in development.
“We think that Medtronic is making a very bold and important move here that shows tremendous courage and is the absolutely right thing for the diabetes community,” said Howard Look, founder, and CEO of Tidepool in a company blog post.
“Medtronic makes incredibly robust and reliable pump hardware, and they have extensive marketing, sales, and support organizations for people with diabetes and for healthcare providers,” Look added. “This network can help bring closed-loop systems to more people living with diabetes.”
As part of the agreement, Medtronic will contribute financial support to Tidepool for the integration development effort and develop a software development kit to enable the iPhone to pump communication.
Both companies will be working closely with the Food and Drug Administration (FDA) through the regulatory process to garner approvals for both the Tidepool Loop app and the future Bluetooth-enabled MiniMed(TM) pump that will work with Tidepool Loop.
This includes pursuing Integrated Continuous Glucose Monitoring (iCGM) classification for the Guardian(TM) Sensor 3 and ACE (Alternate Controller Enabled) pump classification for a future Bluetooth-enabled MiniMed pump.
This would enable an FDA-cleared interoperable system – with ACE pump and iCGM sensor components – that may be mixed and matched with the Tidepool Loop app as the user chooses.
“We have been listening and engaging with the diabetes community to understand what is important to them,” said Ali Dianaty, vice president of research and development for the Diabetes Group at Medtronic. “We recognize that collaboration with Tidepool is a way to further drive industry innovation.”
Dianaty adds that by working with Tidepool and supporting interoperability, they can increase the options available for people with diabetes to manage their condition as they seek out solutions that help them achieve better health and improve quality of life.
Tidepool Loop will be an automated insulin delivery app for iPhone and Apple Watch that connects to an insulin pump and CGM using Bluetooth LE.
It runs an algorithm every five minutes to adjust a user’s basal rate for the next 30 minutes, with the goal to help reduce or avoid high and low blood glucose.
Tidepool intends to deliver Tidepool Loop as an FDA-regulated product, broadly available via the iOS App Store, compatible with multiple, in-warranty pumps and CGMs.
Tidepool and Medtronic.
- Tidepool and Medtronic. (2019, June 21). Medtronic and Tidepool Work Together on Interoperable Automated Insulin Pump System for Diabetes Management. Retrieved June 21, 2019, from http://newsroom.medtronic.com/phoenix.zhtml?c=251324&p=irol-newsArticle&ID=2400972